Diplomat to distribute new primary hyperkalemic, hypokalemic periodic paralysis treatment
Diplomat Pharmacy, Inc. announced on Thursday it will be the sole distributor of KEVEYIS (dichlorphenamide), recently approved for the treatment of primary hyperkalemic and hypokalemic periodic paralysis, a group of rare hereditary disorders that cause episodes of muscle weakness or paralysis. Read More »